For decades, cachexia was thought of as an unfortunate and untreatable byproduct of cancer. But a new understanding of the muscle-wasting syndrome, which is present in about 80 percent of cancer patients, has led to a surge of research. DCI's Jeffrey Crawford, MD, spoke to Let's Win Pancreatic Cancer about current clinical trials. https://duke.is/5/fmzq #PancreaticCancer | #CancerResearch | Duke University School of Medicine | Duke Health
Duke Cancer Institute
Hospitals and Health Care
Durham, North Carolina 5,335 followers
Cancer care as it should be
About us
Duke Cancer Institute is a collaborative powerhouse—audacious, evolving, unconventional—at the center of a world-renowned university and medical center. We unleash the power of synchronous collaboration to create breakthroughs that rapidly transform the unimagined into the possible—to fuel a pace of discoveries and advances previously thought impossible. Established in 1973 as one of the original eight comprehensive cancer centers designated by the National Cancer Institute (NCI), today our patients come for care from every county in North Carolina, every state in the nation and from around the world.
- Website
-
http://www.dukecancerinstitute.org/
External link for Duke Cancer Institute
- Industry
- Hospitals and Health Care
- Company size
- 501-1,000 employees
- Headquarters
- Durham, North Carolina
- Type
- Nonprofit
- Founded
- 1973
Locations
-
Primary
Get directions
20 Duke Medicine Circle
Durham, North Carolina 27710, US
Employees at Duke Cancer Institute
Updates
-
DCI's Zhao Zhang, PhD, refuses to play it safe as he changes what we know about the biology of cancer. Through his studies and clinical trials, Dr. Zhang seeks to create therapies for killer cancers. https://duke.is/y/yrnu #CancerBiology | #Cancer Research | Duke University School of Medicine | Duke Department of Pharmacology and Cancer Biology
-
New results from a clinical trial led by DCI's Nicholas DeVito, MD, are the first to demonstrate the potential of immunotherapy by itself as the initial treatment for patients with the most common type of colorectal cancer. https://duke.is/r/d9j6 #ColorectalCancer | #Immunotherapy | Duke Health
-
Several studies have supported what many clinicians are seeing: a steady increase in patients under age 50 being diagnosed with colorectal cancer. While some attribute the rise to risk factors linked to accelerated aging, such as ultra-processed food, obesity, and sedentary lifestyles, Duke researchers are examining additional environmental or lifestyle factors. https://duke.is/c/7nvs #ColorectalCancer | #CancerResearch | Duke Health
-
🎉 Congratulations to the ten DCI members who were recently promoted to full professors at Duke University! https://duke.is/j/8sm7 Duke University School of Medicine | Duke Faculty Advancement
-
As part of an OncLive Peer Exchange series, DCI's Richard Riedel, MD, discusses contemporary multidisciplinary management of desmoid tumor across the full care continuum. https://duke.is/8/k2jz Duke Health
-
DCI's Georgia Beasley, MD, spoke at Melanoma Research Alliance’s 2026 Patient Forum on how melanoma patient samples drive research and why this contribution matters. https://duke.is/b/m59d #Melanoma | Duke Health
-
Duke Health is among the first centers in the United States to perform complex lung autotransplantation procedures to treat lung cancer, which can be a preferred alternative to standard pneumonectomy. https://duke.is/c/r8x7 #LungCancer | Duke Health
-
DCI Interim Executive Director Erik Sulman, MD, PhD, spoke on a panel at the American Cancer Society and American Cancer Society Cancer Action Network (ACS CAN) North Carolina Research Symposium on updates and optimism about the future of cancer research. https://duke.is/6/bjtf #CancerResearch | Duke Radiation Oncology | Duke University School of Medicine
-
🎉 Congratulations to DCI's Gayle DiLalla, MD, on being named the Association Of Women Surgeons 2026 Kim Ephgrave Visiting Professor! https://duke.is/8/2872 Duke Surgery | Duke University School of Medicine
